Literature DB >> 8005923

Prognosis of single unprovoked seizure.

S K Gupta1, P Satishchandra, A Venkatesh, D K Subbakrishna.   

Abstract

201 patients (131 males and 70 females) with mean age of 18 years (range 5-55 years) who presented at median of 6 days after the onset of first unprovoked seizure were studied. They were followed for a mean period of 60 months (range 12-84 months). One hundred and fifty four (76%) patients were treated with anticonvulsant medication (group A) on a non-randomized basis and the remaining 47 patients (24%) were not treated (group B). Both the groups were comparable for age, sex, type of seizure and interval between onset of seizure and consultation. The cumulative risk of recurrence for entire study group was 24% at 1 month, 32% at 6 months, 34% at 12 months, 35% at 24 months and 36% at 36 months. The cumulative risk of recurrence in group A was 23%, 30%, 32%, 33% and 33% as compared to 28%, 36%, 40%, 43% and 45% at 1, 6, 12, 24 and 36 months respectively (p > 0.05). Maximum number of recurrences (67%) occurred within 1 month. No recurrence occurred after 36 months after the onset of first seizure. Age at onset, sex, seizure type, family history of seizure, EEG abnormalities and nature of antiepileptic drugs did not influence the risk of recurrence.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8005923

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  3 in total

1.  Clinical profile of Solitary Seizures.

Authors:  S K Jha
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 2.  Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure.

Authors:  Maurizio A Leone; Giorgia Giussani; Sarah J Nolan; Anthony G Marson; Ettore Beghi
Journal:  Cochrane Database Syst Rev       Date:  2016-05-06

3.  Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure.

Authors:  Maurizio A Leone; Giorgia Giussani; Sarah J Nevitt; Anthony G Marson; Ettore Beghi
Journal:  Cochrane Database Syst Rev       Date:  2021-05-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.